trending Market Intelligence /marketintelligence/en/news-insights/trending/uztjxs7pgdoxnbrjfgbdkw2 content esgSubNav
In This List

Arena Pharmaceuticals plans common stock offering

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Arena Pharmaceuticals plans common stock offering

Arena Pharmaceuticals Inc. plans to sell 7.5 million of its common stock in an underwritten public offering.

The company plans to grant the underwriters an option to buy up to an additional 1,125,000 shares.

Citigroup, Leerink Partners, Cantor, Credit Suisse and RBC Capital Markets are acting as joint book-running managers, while Guggenheim Securities and JMP Securities are acting as co-managers for the offering.